Renovator Pharmaceuticals Private Limited

Renovator Pharmaceuticals Private Limited - consumer electronics & durables in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U29100UP2013PTC059926 Incorporated 07 October 2013 ROC Kanpur HQ Noida, Uttar Pradesh, India
Active Private Limited Company consumer electronics and durables
Data last updated
Revenue · FY 2025
₹26.7 Lakh
▲ 3.02% YoY
Net profit · FY 2025
₹3.76 Lakh
Net margin 14.1%
EBITDA · FY 2025
₹7.57 Lakh
EBITDA margin 28.3%
Authorised capital
₹18 Lakh
Registered with MCA
Paid-up capital
₹17.4 Lakh
Issued & subscribed
Open charges
₹41 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings

About Renovator Pharmaceuticals Private Limited

Data last updated:

Renovator Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the electronics manufacturing segment of the consumer electronics and durables sector. It was incorporated on 07 October 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U29100UP2013PTC059926.

The company has an authorised share capital of ₹18 Lakh and a paid-up capital of ₹17.4 Lakh. It is led by directors Sandeep Singh and Jyoti Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. K – 70 Site – 5 Upsidc Kasna Greater Noida G.B. Nagar, Uttar Pradesh, India – 201308.

As per the financials filed for FY 2025, the company reported a revenue of ₹26.7 Lakh. For the same year it recorded a net profit of ₹3.76 Lakh (net margin 14.1%) and EBITDA of ₹7.57 Lakh (EBITDA margin 28.3%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 71% over five years.

As per MCA filings, the company has open charges of ₹41 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U29100UP2013PTC059926
Registration Number 059926
Incorporation Date 07 October 2013
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Renovator Pharmaceuticals has one previous CIN (Corporate Identification Number): U24100UP2013PTC059926. The current CIN is U29100UP2013PTC059926, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U29100UP2013PTC059926Current
U24100UP2013PTC059926Previous

Contact details

Renovator Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    No. K – 70 Site – 5 Upsidc Kasna Greater Noida G.B. Nagar, Uttar Pradesh, India – 201308
  • Industry
    Consumer Electronics & Durables, Electronics Manufacturing

To see the full contact details of Renovator Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Renovator Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Renovator Pharmaceuticals is manufacturing. In detail, this covers electrical equipment, general purpose and special purpose machinery & equipment, transport equipment.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC10Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment

To see the full business activity and turnover split of Renovator Pharmaceuticals Private Limited, buy the company report.

Financials of Renovator Pharmaceuticals Private Limited

FY 2025 filings available

Renovator Pharmaceuticals Private Limited reported revenue of ₹26.7 Lakh for FY 2025.

Revenue · FY 2025
₹26.7 Lakh
Net profit · FY 2025
₹3.76 Lakh margin 14.1%
EBITDA · FY 2025
₹7.57 Lakh margin 28.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 8%
5 years · compounded
▲ 71%
EBITDA CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 45%
5 years · compounded
▲ 46%

Revenue has grown at a compounded annual rate (CAGR) of 71% over five years. EBITDA rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7.57 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.76 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin28.3%
Net Profit Margin14.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Renovator Pharmaceuticals Private Limited, buy the company report.

Board of directors of Renovator Pharmaceuticals Private Limited

Renovator Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sandeep SinghDirector07 Oct 201313 Years 0 MonthsCurrent
Jyoti SinghDirector02 Jun 201610 Years 4 MonthsCurrent

Auditor

Renovator Pharmaceuticals Private Limited is audited by ABHISHEK SRIVASTAVA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
ABHISHEK SRIVASTAVA & CO.FY 2023024877C

Shareholding

The shareholding of Renovator Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Renovator Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹41 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.41 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
14 Jul 2018100235512Others₹41 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Renovator Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Renovator Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Renovator Pharmaceuticals Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Deepak Singh ceased to be Director on 04 Dec 2020.

AGM
Renovator Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Renovator Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Deepak Singh ceased to be Director.
Ceased
Preeti Singh ceased to be Director.
Charges
A charge with Others amounted to Rs. 41.00 Lakh with Charge ID 100235512 was registered on 14 Jul 2018.
Ceased
Jyoti Singh ceased to be Additional Director.
Appointed
Jyoti Singh was appointed as Director.
Appointed
Sandeep Singh was appointed as Director.
Incorporation
07 Oct 2013
Renovator Pharmaceuticals Private Limited was registered on 07 Oct 2013 with Roc Kanpur & aged 13 years 25 days as per MCA records.

Frequently asked questions

Renovator Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in electronics manufacturing, within the consumer electronics and durables industry. It was incorporated on 07 October 2013 (13+ years old) and is registered under CIN U29100UP2013PTC059926.

Renovator Pharmaceuticals has 2 current directors:

The latest financial statements of Renovator Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Renovator Pharmaceuticals is U29100UP2013PTC059926. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Renovator Pharmaceuticals was incorporated on 07 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kanpur.

Deepak Singh ceased to be Director on 04 Dec 2020. Preeti Singh ceased to be Director on 04 Dec 2020. Jyoti Singh ceased to be Additional Director on 30 Sep 2017. Renovator Pharmaceuticals has 5 board changes on record in total.

The registered office of Renovator Pharmaceuticals is at No. K – 70 Site – 5 Upsidc Kasna Greater Noida G.B. Nagar, Uttar Pradesh, India – 201308.

Renovator Pharmaceuticals operates in the consumer electronics and durables industry, in the electronics manufacturing segment.

Renovator Pharmaceuticals has open charges of ₹41 Lakh and no satisfied charges on record as per latest MCA filings.

The compliance status of Renovator Pharmaceuticals is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.